Emergency use of vaccine approved in Brazil
Currently, Brazil has 6 million doses of Sinovac’s CoronaVac ready to be distributed over the next few days and is awaiting the arrival of another 2 million doses of AstraZeneca vaccine.
Brazilian health regulator Anvisa on Sunday approved the emergency use of the COVID-19 vaccines from China’s Sinovac Biotech Ltd and Britain’s AstraZeneca. Authorities reported 550 new fatalities on Sunday. President Jair Bolsonaro has been heavily criticised for his handling of the pandemic.
The President government is considering extending the time between the application of the first and second doses of immunisers to reach more people quickly, health minister Eduardo Pazuello said in Manaus on Monday.
The hospitals in Manaus, a city of almost 2.2 million people have admitted few new COVID-19 patients due to the lack of oxygen supply causing many to suffer from the disease at home and some to die. Other Brazilian states have offered to receive patients and decongest Manaus’s health system.
The president, who got COVID-19 last year and recovered, has said that he will not take the vaccine and has raised suspicions about the effectiveness of the Chinese vaccine. Some scientists warn that not enough data has been published about the effectiveness or the safety of the Sinovac’s vaccine.